Es gab 50 kürzliche Insider-Transaktionen für Northwest Biotherapeutics, Inc. (NWBO), darunter 30 Käufe und 8 Verkäufe. Die gesamten Insider-Käufe beliefen sich auf $47.68M und die gesamten Insider-Verkäufe auf $7.48M.
Bedeutende Insider mit kürzlicher Aktivität umfassen Boynton Alton L, Bosch Marnix L, Malik Navid. Insider-Transaktionen können Einblicke geben, wie die Unternehmensführung die Bewertung und Zukunftsaussichten der Aktie einschätzt.
Insider-Transaktionen — NWBO
| Datum |
Name |
Funktion |
Transaktionsart |
Aktien |
Ø Preis |
Wert |
Gehaltene Aktien |
| 2024-08-29 |
Boynton Alton L |
Chief Scientific Officer |
Schenkung (gegeben) |
1,000,000 |
$0.23 |
$230K |
967,065 |
| 2024-08-09 |
Bosch Marnix L |
Chief Technical Officer |
Schenkung (gegeben) |
3,000,000 |
$0.35 |
$1.05M |
4,549,157 |
| 2024-08-08 |
Boynton Alton L |
Chief Scientific Officer |
Schenkung (gegeben) |
1,000,000 |
$0.23 |
$230K |
1,967,065 |
| 2024-07-26 |
Malik Navid |
Director |
Informierter Verkauf |
657,895 |
$0.23 |
$151.32K |
23,339,393 |
| 2023-11-17 |
Malik Navid |
Director |
Informierter Kauf |
295,000 |
$0.82 |
$241.61K |
- |
| 2023-11-16 |
Malik Navid |
Director |
Informierter Kauf |
125,000 |
$0.84 |
$104.38K |
445,000 |
| 2023-04-04 |
Boynton Alton L |
Chief Scientific Officer |
Schenkung (gegeben) |
6,794,191 |
$0.35 |
$2.38M |
2,967,065 |
| 2023-04-03 |
Bosch Marnix L |
Chief Technical Officer |
RSU-Zuteilung |
119,355 |
$0.25 |
$29.84K |
119,355 |
| 2022-12-06 |
Boynton Alton L |
Chief Scientific Officer |
Schenkung (gegeben) |
4,500,000 |
$0.35 |
$1.58M |
9,761,256 |
| 2022-12-01 |
Jasinowski Jerry J |
Director |
RSU-Zuteilung |
28,235 |
$21.25 |
$599.99K |
28,235 |
| 2022-05-26 |
Boynton Alton L |
Chief Scientific Officer |
Schenkung (gegeben) |
4,900,000 |
$0.23 |
$1.13M |
9,761,256 |
| 2021-01-19 |
Boynton Alton L |
Chief Scientific Officer |
Schenkung (gegeben) |
3,402,935 |
$0.25 |
$850.73K |
- |
| 2020-10-14 |
Powers Linda F |
10 Percent Owner, Officer: President and CEO |
Schenkung (gegeben) |
3,000,000 |
$0.25 |
$750K |
29,558,724 |
| 2020-07-02 |
Bosch Marnix L |
Chief Technical Officer |
RSU-Zuteilung |
3,249,572 |
$0.21 |
$682.41K |
3,249,572 |
| 2020-07-02 |
Boynton Alton L |
Chief Scientific Officer |
RSU-Zuteilung |
605,160 |
$0.25 |
$151.29K |
605,160 |
| 2020-07-02 |
Powers Linda F |
10 Percent Owner, Officer: President and CEO |
RSU-Zuteilung |
15,249,474 |
$0.21 |
$3.2M |
15,249,474 |
| 2020-07-02 |
Goldman Leslie J. |
See Remarks |
RSU-Zuteilung |
1,315,566 |
$0.25 |
$328.89K |
1,315,566 |
| 2020-04-30 |
Powers Linda F |
President and CEO |
Option verfallen |
29,411,760 |
$0.22 |
$6.47M |
- |
| 2020-02-03 |
Jasinowski Jerry J |
Director |
RSU-Zuteilung |
526,316 |
$0.19 |
$100K |
1,891,347 |
| 2019-12-09 |
Davis Jean M. |
Officer |
Unbekannt |
- |
- |
- |
- |
| 2018-12-28 |
Powers Linda F |
10 Percent Owner, Officer: President and CEO |
Informierter Verkauf |
804,146 |
$0.17 |
$136.7K |
- |
| 2018-12-27 |
Powers Linda F |
10 Percent Owner, Officer: President and CEO |
Informierter Verkauf |
1,779,320 |
$0.30 |
$533.8K |
- |
| 2018-05-28 |
Jasinowski Jerry J |
Director |
RSU-Zuteilung |
4,900,000 |
$0.23 |
$1.13M |
4,900,000 |
| 2018-05-28 |
Boynton Alton L |
Director |
RSU-Zuteilung |
4,900,000 |
$0.23 |
$1.13M |
11,270,000 |
| 2018-05-28 |
Powers Linda F |
Director |
RSU-Zuteilung |
39,200,000 |
$0.23 |
$9.02M |
39,200,000 |
| 2018-05-28 |
Black Cofer |
Director |
RSU-Zuteilung |
1,715,000 |
$0.23 |
$394.45K |
1,715,000 |
| 2018-05-28 |
Malik Navid |
Director |
RSU-Zuteilung |
9,065,000 |
$0.23 |
$2.08M |
9,065,000 |
| 2018-05-28 |
Goldman Leslie J. |
Senior Vice President |
RSU-Zuteilung |
24,500,000 |
$0.23 |
$5.64M |
24,500,000 |
| 2018-03-19 |
Powers Linda F |
President and CEO |
RSU-Zuteilung |
- |
- |
- |
- |
| 2018-03-19 |
Powers Linda F |
President and CEO |
RSU-Zuteilung |
- |
- |
- |
- |
| 2018-03-14 |
Powers Linda F |
President and CEO |
RSU-Zuteilung |
- |
- |
- |
- |
| 2018-03-12 |
Powers Linda F |
President and CEO |
Sonstige (Kauf) |
2,941,176 |
- |
- |
2,941,176 |
| 2017-06-13 |
Boynton Alton L |
Chief Scientific Officer |
RSU-Zuteilung |
3,402,935 |
$0.25 |
$850.73K |
3,402,935 |
| 2017-06-13 |
Bosch Marnix L |
Chief Technical Officer |
Optionsausübung |
7,940,182 |
$0.25 |
$1.99M |
7,940,182 |
| 2016-01-25 |
Bayh Susan B |
Director |
Unbekannt |
- |
- |
- |
- |
| 2016-01-25 |
Black Cofer |
Director |
Unbekannt |
- |
- |
- |
- |
| 2015-11-05 |
Woodford Investment Management Llp |
10 Percent Owner |
Veräußerung |
- |
- |
- |
18,316,679 |
| 2015-06-30 |
Cognate Bioservices, Inc. |
10 Percent Owner |
Informierter Verkauf |
1,118,092 |
$4.22 |
$4.72M |
18,460,390 |
| 2014-09-15 |
Cognate Bioservices, Inc. |
10 Percent Owner |
Informierter Verkauf |
149,502 |
$5.02 |
$750.5K |
20,228,482 |
| 2014-09-01 |
Cognate Bioservices, Inc. |
10 Percent Owner |
Informierter Kauf |
319,554 |
$4.00 |
$1.28M |
319,554 |
| 2014-08-27 |
Cognate Bioservices, Inc. |
10 Percent Owner |
Informierter Verkauf |
145,068 |
$5.17 |
$750K |
19,738,876 |
| 2014-08-01 |
Cognate Bioservices, Inc. |
10 Percent Owner |
Informierter Kauf |
275,110 |
$4.00 |
$1.1M |
275,110 |
| 2014-08-01 |
Farmer Robert A |
Director |
Optionsausübung (ITM) |
1,507 |
$5.60 |
$8.44K |
9,859 |
| 2014-07-17 |
Cognate Bioservices, Inc. |
10 Percent Owner |
Sonstige (Kauf) |
3,220,235 |
$4.00 |
$12.88M |
3,220,235 |
| 2014-07-01 |
Cognate Bioservices, Inc. |
10 Percent Owner |
Informierter Kauf |
398,439 |
$4.00 |
$1.59M |
398,439 |
| 2014-06-30 |
Cognate Bioservices, Inc. |
10 Percent Owner |
Informierter Kauf |
281,250 |
$4.00 |
$1.13M |
281,250 |
| 2014-06-01 |
Cognate Bioservices, Inc. |
10 Percent Owner |
Informierter Kauf |
192,600 |
$4.00 |
$770.4K |
192,600 |
| 2014-05-01 |
Cognate Bioservices, Inc. |
10 Percent Owner |
Informierter Kauf |
170,985 |
$4.00 |
$683.94K |
170,985 |
| 2014-04-01 |
Cognate Bioservices, Inc. |
10 Percent Owner |
Informierter Kauf |
144,766 |
$4.00 |
$579.06K |
144,766 |
| 2014-03-07 |
Cognate Bioservices, Inc. |
10 Percent Owner |
Informierter Verkauf |
120,370 |
$3.64 |
$438.15K |
16,957,525 |
■ Informativ — Transaktion am offenen Markt (bedeutendste)
■ Nicht-informativ (Kauf) — Vergütung, Optionsausübung, Wandlung
■ Nicht-informativ (Verkauf) — Quellensteuer, Verkauf bei Vesting
■ Neutral — Schenkung, Treuhand, Verfall